Moderna COVID-19 vaccine has 'favorable safety profile,' FDA documents show, putting it closer to approval

The Food and Drug Administration released documents detailing Moderna's coronavirus vaccine candidate's "favorable safety profile" on Tuesday ahead of a key committee meeting scheduled for Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.